The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Giuffre Randall Michael since 2018.
This trader's CIK number is 1759822.
At the time of last reporting, Giuffre Randall Michael was the Director of Diamedica Therapeutics Inc.. (stock ticker symbol DMAC).
Also see all insider trading activities at Diamedica Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | DMAC | 65,000 | $254,150 | 0 | $0 | 0 | $0 |
| 2022 | DMAC | 68,047 | $81,435 | 0 | $0 | 0 | $0 |
| 2020 | DMAC | 15,000 | $63,915 | 0 | $0 | 0 | $0 |
| 2018 | DMAC | 11,250 | $45,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-23 | DMAC | Buy | 65,000 | 3.91 | 254,150 |
| 2022-12-01 | DMAC | Buy | 819 | 1.19 | 974 |
| 2022-11-30 | DMAC | Buy | 2,970 | 1.19 | 3,534 |
| 2022-11-29 | DMAC | Buy | 18,125 | 1.19 | 21,568 |
| 2022-12-01 | DMAC | Buy | 46,133 | 1.20 | 55,359 |
| 2020-11-20 | DMAC | Buy | 15,000 | 4.26 | 63,915 |
| 2018-12-11 | DMAC | Buy | 11,250 | 4.00 | 45,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Giuffre Randall Michael (Director of Diamedica Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.